Reduction in All-Cause Mortality with Fluticasone (FF/UMEC/VI) in COPD Patients
Dr. John Fleetham sits down with Drs. David Lipson and Jorgen Vestbo to discuss the article "Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients".
The article discussed in today's episode is Open Access and can be found here:
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients